TNFRSF4 and autoimmune disease: Research over the past decade has definitively shown the importance of OX40–OX40L interactions in development of immune-mediated disease24, based on that the OX40–OX40L checkpoint inhibition may have potential clinical application in the treatment in autoimmune diseases.